Bioinformatics · 2012 · 132 citations · 18 references
PharmacyBioinformaticsPharmacologyDrug DiscoveryDrug InteractionsPharmacogenomicsAdverse Drug Event ReportingAdverse Drug Reaction PredictionAdverse Drug Reaction ReportingAdverse Drug ReactionsDrug-target Interaction MappingAdverse Drug Event PredictionAdverse Event PredictionCompound-target Interaction PredictionComputational Off-target PredictionDrug Repositioning InformaticsDrug-target Interaction DatabasesGenomic Similarity MetricsSequence Similarity
MOTIVATION: Unexpected drug activities derived from off-targets are usually undesired and harmful; however, they can occasionally be beneficial for different therapeutic indications. There are many uncharacterized drugs whose target proteins (including the primary target and off-targets) remain unknown. The identification of all potential drug targets has become an important issue in drug repositioning to reuse known drugs for new therapeutic indications. RESULTS: We defined pharmacological similarity for all possible drugs using the US Food and Drug Administration's (FDA's) adverse event reporting system (AERS) and developed a new method to predict unknown drug-target interactions on a large scale from the integration of pharmacological similarity of drugs and genomic sequence similarity of target proteins in the framework of a pharmacogenomic approach. The proposed method was applicable to a large number of drugs and it was useful especially for predicting unknown drug-target interactions that could not be expected from drug chemical structures. We made a comprehensive prediction for potential off-targets of 1874 drugs with known targets and potential target profiles of 2519 drugs without known targets, which suggests many potential drug-target interactions that were not predicted by previous chemogenomic or pharmacogenomic approaches. AVAILABILITY: Softwares are available upon request. CONTACT: yamanishi@bioreg.kyushu-u.ac.jp SUPPLEMENTARY INFORMATION: Datasets and all results are available at http://cbio.ensmp.fr/~yyamanishi/aers/.
18
KEGG for linking genomes to life and the environment
Minoru Kanehisa, Michihiro Araki, Susumu Goto et al. · Nucleic Acids Research · 2007 · 7.1K citations · Full text
From genomics to chemical genomics: new developments in KEGG
Minoru Kanehisa · Nucleic Acids Research · 2005 · 3.2K citations · Full text
Predicting new molecular targets for known drugs
Michael J. Keiser, Vincent Setola, John J. Irwin et al. · Nature · 2009 · 1.7K citations
Drug Target Identification Using Side-Effect Similarity
Mónica Campillos, Michael Kuhn, Anne‐Claude Gavin et al. · Science · 2008 · 1.2K citations